Autoreactive T cells target peripheral nerves in Guillain-Barré syndrome.
Journal
Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462
Informations de publication
Date de publication:
17 Jan 2024
17 Jan 2024
Historique:
received:
16
03
2023
accepted:
30
11
2023
medline:
18
1
2024
pubmed:
18
1
2024
entrez:
17
1
2024
Statut:
aheadofprint
Résumé
Guillain-Barré syndrome (GBS) is a rare heterogenous disorder of the peripheral nervous system, which is usually triggered by a preceding infection, and causes a potentially life-threatening progressive muscle weakness
Identifiants
pubmed: 38233524
doi: 10.1038/s41586-023-06916-6
pii: 10.1038/s41586-023-06916-6
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
Shahrizaila, N., Lehmann, H. C. & Kuwabara, S. Guillain–Barré syndrome. Lancet 397, 1214–1228 (2021).
pubmed: 33647239
doi: 10.1016/S0140-6736(21)00517-1
Doets, A. Y. et al. Regional variation of Guillain–Barré syndrome. Brain 141, 2866–2877 (2018).
pubmed: 30247567
doi: 10.1093/brain/awy232
Cao-Lormeau, V. M. et al. Guillain–Barré syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet 387, 1531–1539 (2016).
pubmed: 26948433
pmcid: 5444521
doi: 10.1016/S0140-6736(16)00562-6
Patone, M. et al. Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nat. Med. 27, 2144–2153 (2021).
pubmed: 34697502
pmcid: 8629105
doi: 10.1038/s41591-021-01556-7
Luijten, L. W. G. et al. Guillain–Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study. Brain 144, 3392–3404 (2021).
pubmed: 34553216
pmcid: 8677532
doi: 10.1093/brain/awab279
Blum, S. et al. Genome-wide association study in Guillain–Barré syndrome. J. Neuroimmunol. 323, 109–114 (2018).
pubmed: 30196823
doi: 10.1016/j.jneuroim.2018.07.016
Geleijns, K. et al. HLA class II alleles are not a general susceptibility factor in Guillain–Barré syndrome. Neurology 64, 44–49 (2005).
pubmed: 15642902
doi: 10.1212/01.WNL.0000148727.02732.01
Zhao, Y., Zhu, R., Tian, D. & Liu, X. Genetic polymorphisms in Guillain–Barré syndrome: a field synopsis and systematic meta-analysis. Autoimmun. Rev. 19, 102665 (2020).
pubmed: 32949724
doi: 10.1016/j.autrev.2020.102665
Yuki, N. Ganglioside mimicry and peripheral nerve disease. Muscle Nerve 35, 691–711 (2007).
pubmed: 17373701
doi: 10.1002/mus.20762
Laman, J. D., Huizinga, R., Boons, G. J. & Jacobs, B. C. Guillain–Barré syndrome: expanding the concept of molecular mimicry. Trends Immunol. 43, 296–308 (2022).
pubmed: 35256276
pmcid: 9016725
doi: 10.1016/j.it.2022.02.003
Morell, P. Q. & Quarles, R. H. in Basic Neurochemistry: Molecular, Cellular and Medical Aspects 6th edn (eds Siegel, G. J. et al.) Ch. 4 (Lippincott-Raven, 1999).
Wanschitz, J., Maier, H., Lassmann, H., Budka, H. & Berger, T. Distinct time pattern of complement activation and cytotoxic T cell response in Guillain–Barré syndrome. Brain 126, 2034–2042 (2003).
pubmed: 12847075
doi: 10.1093/brain/awg207
Schmidt, B. et al. Inflammatory infiltrates in sural nerve biopsies in Guillain–Barré syndrome and chronic inflammatory demyelinating neuropathy. Muscle Nerve 19, 474–487 (1996).
pubmed: 8622727
doi: 10.1002/(SICI)1097-4598(199604)19:4<474::AID-MUS8>3.0.CO;2-9
Taylor, W. A. & Hughes, R. A. T lymphocyte activation antigens in Guillain–Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy. J. Neuroimmunol. 24, 33–39 (1989).
pubmed: 2808686
doi: 10.1016/0165-5728(89)90095-7
Chi, L. J., Wang, H. B., Zhang, Y. & Wang, W. Z. Abnormality of circulating CD4
pubmed: 17997492
doi: 10.1016/j.jneuroim.2007.09.034
Harness, J. & McCombe, P. A. Increased levels of activated T-cells and reduced levels of CD4/CD25
pubmed: 18653346
doi: 10.1016/j.jocn.2007.09.016
Pritchard, J., Makowska, A., Gregson, N. A., Hayday, A. C. & Hughes, R. A. Reduced circulating CD4
pubmed: 17239444
doi: 10.1016/j.jneuroim.2006.12.002
Han, R. K. et al. Increased circulating Th17 cell populations and elevated CSF osteopontin and IL-17 concentrations in patients with Guillain–Barré syndrome. J. Clin. Immunol. 34, 94–103 (2014).
pubmed: 24217817
doi: 10.1007/s10875-013-9965-3
Wang, H. et al. Expression and significance of CD4
pubmed: 26770543
pmcid: 4694443
Che, Y. et al. Circulating memory T follicular helper subsets, Tfh2 and Tfh17, participate in the pathogenesis of Guillain–Barré syndrome. Sci. Rep. 6, 20963 (2016).
pubmed: 26865046
pmcid: 4750093
doi: 10.1038/srep20963
Dahle, C., Vrethem, M. & Ernerudh, J. T lymphocyte subset abnormalities in peripheral blood from patients with the Guillain–Barré syndrome. J. Neuroimmunol. 53, 219–225 (1994).
pubmed: 7520920
doi: 10.1016/0165-5728(94)90032-9
Khalili-Shirazi, A., Hughes, R. A., Brostoff, S. W., Linington, C. & Gregson, N. T cell responses to myelin proteins in Guillain–Barré syndrome. J. Neurol. Sci. 111, 200–203 (1992).
pubmed: 1279128
doi: 10.1016/0022-510X(92)90069-W
Taylor, W. A., Brostoff, S. W. & Hughes, R. A. P2 specific lymphocyte transformation in Guillain–Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy. J. Neurol. Sci. 104, 52–55 (1991).
pubmed: 1717662
doi: 10.1016/0022-510X(91)90215-S
Csurhes, P. A., Sullivan, A. A., Green, K., Pender, M. P. & McCombe, P. A. T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain–Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. J. Neurol. Neurosurg. Psychiatry 76, 1431–1439 (2005).
pubmed: 16170091
pmcid: 1739377
doi: 10.1136/jnnp.2004.052282
Whitfield, M. L., George, L. K., Grant, G. D. & Perou, C. M. Common markers of proliferation. Nat. Rev. Cancer 6, 99–106 (2006).
pubmed: 16491069
doi: 10.1038/nrc1802
Kowalczyk, M. S. et al. Single-cell RNA-seq reveals changes in cell cycle and differentiation programs upon aging of hematopoietic stem cells. Genome Res. 25, 1860–1872 (2015).
pubmed: 26430063
pmcid: 4665007
doi: 10.1101/gr.192237.115
Cassotta, A. et al. Broadly reactive human CD4
pubmed: 33226131
doi: 10.1002/eji.202048630
Low, J. S. et al. Clonal analysis of immunodominance and cross-reactivity of the CD4 T cell response to SARS-CoV-2. Science 372, 1336–1341 (2021).
pubmed: 34006597
doi: 10.1126/science.abg8985
Latorre, D. et al. T cells in patients with narcolepsy target self-antigens of hypocretin neurons. Nature 562, 63–68 (2018).
pubmed: 30232458
doi: 10.1038/s41586-018-0540-1
Gomez-Tourino, I., Kamra, Y., Baptista, R., Lorenc, A. & Peakman, M. T cell receptor β-chains display abnormal shortening and repertoire sharing in type 1 diabetes. Nat. Commun. 8, 1792 (2017).
pubmed: 29176645
pmcid: 5702608
doi: 10.1038/s41467-017-01925-2
Schneider-Hohendorf, T. et al. CD8
pubmed: 27040081
pmcid: 4822013
doi: 10.1038/ncomms11153
Huang, H., Wang, C., Rubelt, F., Scriba, T. J. & Davis, M. M. Analyzing the Mycobacterium tuberculosis immune response by T-cell receptor clustering with GLIPH2 and genome-wide antigen screening. Nat. Biotechnol. 38, 1194–1202 (2020).
pubmed: 32341563
pmcid: 7541396
doi: 10.1038/s41587-020-0505-4
Chour, W. et al. Shared antigen-specific CD8
Shugay, M. et al. VDJdb: a curated database of T-cell receptor sequences with known antigen specificity. Nucleic Acids Res. 46, D419–D427 (2018).
pubmed: 28977646
doi: 10.1093/nar/gkx760
Yohannes, D. A. et al. Deep sequencing of blood and gut T-cell receptor β-chains reveals gluten-induced immune signatures in celiac disease. Sci. Rep. 7, 17977 (2017).
pubmed: 29269859
pmcid: 5740085
doi: 10.1038/s41598-017-18137-9
Rosati, E. et al. Identification of disease-associated traits and clonotypes in the T cell receptor repertoire of monozygotic twins affected by inflammatory bowel diseases. J. Crohns Colitis 14, 778–790 (2020).
pubmed: 31711184
doi: 10.1093/ecco-jcc/jjz179
Reynisson, B., Alvarez, B., Paul, S., Peters, B. & Nielsen, M. NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data. Nucleic Acids Res. 48, W449–W454 (2020).
pubmed: 32406916
pmcid: 7319546
doi: 10.1093/nar/gkaa379
Han, H., Myllykoski, M., Ruskamo, S., Wang, C. & Kursula, P. Myelin-specific proteins: a structurally diverse group of membrane-interacting molecules. Biofactors 39, 233–241 (2013).
pubmed: 23780694
doi: 10.1002/biof.1076
Raasakka, A. et al. Molecular structure and function of myelin protein P0 in membrane stacking. Sci. Rep. 9, 642 (2019).
pubmed: 30679613
pmcid: 6345808
doi: 10.1038/s41598-018-37009-4
Shy, M. E. et al. Phenotypic clustering in MPZ mutations. Brain 127, 371–384 (2004).
pubmed: 14711881
doi: 10.1093/brain/awh048
Street, V. A. et al. Charcot–Marie–Tooth neuropathy: clinical phenotypes of four novel mutations in the MPZ and Cx 32 genes. Neuromuscul. Disord. 12, 643–650 (2002).
pubmed: 12207932
doi: 10.1016/S0960-8966(02)00021-4
Plante-Bordeneuve, V. et al. The range of chronic demyelinating neuropathy of infancy: a clinico-pathological and genetic study of 15 unrelated cases. J. Neurol. 248, 795–803 (2001).
pubmed: 11596785
doi: 10.1007/s004150170096
Salomon, B. et al. Development of spontaneous autoimmune peripheral polyneuropathy in B7-2-deficient NOD mice. J. Exp. Med. 194, 677–684 (2001).
pubmed: 11535635
pmcid: 2195945
doi: 10.1084/jem.194.5.677
Louvet, C. et al. A novel myelin P0-specific T cell receptor transgenic mouse develops a fulminant autoimmune peripheral neuropathy. J. Exp. Med. 206, 507–514 (2009).
pubmed: 19221395
pmcid: 2699118
doi: 10.1084/jem.20082113
Gavin, M. A. & Bevan, M. J. Increased peptide promiscuity provides a rationale for the lack of N regions in the neonatal T cell repertoire. Immunity 3, 793–800 (1995).
pubmed: 8777724
doi: 10.1016/1074-7613(95)90068-3
Venturi, V., Price, D. A., Douek, D. C. & Davenport, M. P. The molecular basis for public T-cell responses? Nat. Rev. Immunol. 8, 231–238 (2008).
pubmed: 18301425
doi: 10.1038/nri2260
Lucchese, G. & Floel, A. SARS-CoV-2 and Guillain–Barré syndrome: molecular mimicry with human heat shock proteins as potential pathogenic mechanism. Cell Stress Chaperones 25, 731–735 (2020).
pubmed: 32729001
pmcid: 7387880
doi: 10.1007/s12192-020-01145-6
Shoraka, S., Ferreira, M. L. B., Mohebbi, S. R. & Ghaemi, A. SARS-CoV-2 infection and Guillain–Barré syndrome: a review on potential pathogenic mechanisms. Front. Immunol. 12, 674922 (2021).
pubmed: 34040615
pmcid: 8141918
doi: 10.3389/fimmu.2021.674922
Latorre, D. Autoimmunity and SARS-CoV-2 infection: unraveling the link in neurological disorders. Eur. J. Immunol. 52, 1561–1571 (2022).
pubmed: 35833748
pmcid: 9350097
doi: 10.1002/eji.202149475
Kiefer, R., Kieseier, B. C., Stoll, G. & Hartung, H. P. The role of macrophages in immune-mediated damage to the peripheral nervous system. Prog. Neurobiol. 64, 109–127 (2001).
pubmed: 11240209
doi: 10.1016/S0301-0082(00)00060-5
Meyer Zu Horste, G. et al. Expression of antigen processing and presenting molecules by Schwann cells in inflammatory neuropathies. Glia 58, 80–92 (2010).
pubmed: 19544394
doi: 10.1002/glia.20903
Hartlehnert, M. et al. Schwann cells promote post-traumatic nerve inflammation and neuropathic pain through MHC class II. Sci. Rep. 7, 12518 (2017).
pubmed: 28970572
pmcid: 5624882
doi: 10.1038/s41598-017-12744-2
Meyer zu Horste, G. et al. Mouse Schwann cells activate MHC class I and II restricted T-cell responses, but require external peptide processing for MHC class II presentation. Neurobiol. Dis. 37, 483–490 (2010).
pubmed: 19914379
doi: 10.1016/j.nbd.2009.11.006
Taylor, J. M. & Pollard, J. D. Dominance of autoreactive T cell-mediated delayed-type hypersensitivity or antibody-mediated demyelination results in distinct forms of experimental autoimmune neuritis in the Lewis rat. J. Neuropathol. Exp. Neurol. 60, 637–646 (2001).
pubmed: 11398840
doi: 10.1093/jnen/60.6.637
Quarles, R. H., Ilyas, A. A. & Willison, H. J. Antibodies to gangliosides and myelin proteins in Guillain–Barré syndrome. Ann. Neurol. 27, S48–S52 (1990).
pubmed: 2194427
doi: 10.1002/ana.410270713
Khalili-Shirazi, A., Atkinson, P., Gregson, N. & Hughes, R. A. Antibody responses to P0 and P2 myelin proteins in Guillain–Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy. J. Neuroimmunol. 46, 245–251 (1993).
pubmed: 7689591
doi: 10.1016/0165-5728(93)90255-W
Allen, D. et al. Antibodies to peripheral nerve myelin proteins in chronic inflammatory demyelinating polyradiculoneuropathy. J. Peripher. Nerv. Syst. 10, 174–180 (2005).
pubmed: 15958128
doi: 10.1111/j.1085-9489.2005.0010207.x
Inglis, H. R., Csurhes, P. A. & McCombe, P. A. Antibody responses to peptides of peripheral nerve myelin proteins P0 and P2 in patients with inflammatory demyelinating neuropathy. J. Neurol. Neurosurg. Psychiatry 78, 419–422 (2007).
pubmed: 17158557
doi: 10.1136/jnnp.2006.106617
Makowska, A. et al. Immune responses to myelin proteins in Guillain–Barré syndrome. J. Neurol. Neurosurg. Psychiatry 79, 664–671 (2008).
pubmed: 17717020
doi: 10.1136/jnnp.2007.123943
Gabriel, C. M., Gregson, N. A. & Hughes, R. A. Anti-PMP22 antibodies in patients with inflammatory neuropathy. J. Neuroimmunol. 104, 139–146 (2000).
pubmed: 10713353
doi: 10.1016/S0165-5728(99)00269-6
Asbury, A. K. & Cornblath, D. R. Assessment of current diagnostic criteria for Guillain–Barré syndrome. Ann. Neurol. 27, S21–S24 (1990).
pubmed: 2194422
doi: 10.1002/ana.410270707
Gerna, G. et al. Human cytomegalovirus serum neutralizing antibodies block virus infection of endothelial/epithelial cells, but not fibroblasts, early during primary infection. J. Gen. Virol. 89, 853–865 (2008).
pubmed: 18343825
doi: 10.1099/vir.0.83523-0
Cano-Gamez, E. et al. Single-cell transcriptomics identifies an effectorness gradient shaping the response of CD4
pubmed: 32286271
pmcid: 7156481
doi: 10.1038/s41467-020-15543-y
Szabo, P. A. et al. Single-cell transcriptomics of human T cells reveals tissue and activation signatures in health and disease. Nat. Commun. 10, 4706 (2019).
pubmed: 31624246
pmcid: 6797728
doi: 10.1038/s41467-019-12464-3
Tibbitt, C. A. et al. Single-cell RNA sequencing of the T helper cell response to house dust mites defines a distinct gene expression signature in airway Th2 cells. Immunity 51, 169–184 (2019).
pubmed: 31231035
doi: 10.1016/j.immuni.2019.05.014
Nagai, S. et al. Comprehensive gene expression profile of human activated T
pubmed: 11222506
doi: 10.1093/intimm/13.3.367
Hu, D. et al. Transcriptional signature of human pro-inflammatory TH17 cells identifies reduced IL10 gene expression in multiple sclerosis. Nat. Commun. 8, 1600 (2017).
pubmed: 29150604
pmcid: 5693957
doi: 10.1038/s41467-017-01571-8
Eckstein, M. et al. Cytotoxic T-cell-related gene expression signature predicts improved survival in muscle-invasive urothelial bladder cancer patients after radical cystectomy and adjuvant chemotherapy. J. Immunother. Cancer 8, e000162 (2020).
pubmed: 32448798
pmcid: 7253053
doi: 10.1136/jitc-2019-000162
Li, J. et al. KIR
pubmed: 35258337
pmcid: 8995031
doi: 10.1126/science.abi9591
Borcherding, N. et al. Mapping the immune environment in clear cell renal carcinoma by single-cell genomics. Commun. Biol. 4, 122 (2021).
pubmed: 33504936
pmcid: 7840906
doi: 10.1038/s42003-020-01625-6
Glanville, J. et al. Identifying specificity groups in the T cell receptor repertoire. Nature 547, 94–98 (2017).
pubmed: 28636589
pmcid: 5794212
doi: 10.1038/nature22976